Press releasePRNewswire
Orthofix Medical
OFIX · NASDAQ
$9.85+$0.26 (+2.71%)TodayMarket closed ·
Prev close $9.59
Latest news
- Press releasePRNewswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX)
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
Orthofix Medical Q2 Adj. EPS $0.07 Beats $(0.41) Estimate, Sales $210.933M Beat $209.277M Estimate
- Press releaseBusiness Wire
Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress
- Press releasePRNewswire
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- NewsPiero Cingari
These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why
- Press releasePRNewswire
MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth
- Press releaseBusiness Wire
Orthofix to Participate in Upcoming Investor Conferences
- Press releaseBusiness Wire
Orthofix to Report Second Quarter 2026 Financial Results
- NewsTim Melvin
Alpha Buying: Wall Street Gave Up. Management Didn't.
- Press releasePRNewswire
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Press releasePRNewswire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX)
- Press releaseBusiness Wire
Orthofix to Participate in Upcoming Investor Conferences
- Press releaseBusiness Wire
Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting
- Press releasePRNewswire
Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights
- News
Full Transcript: Orthofix Medical Q1 2026 Earnings Call
- News
Earnings Scheduled For May 5, 2026
- Press releaseBusiness Wire
Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance
- Press releaseBusiness Wire
Orthofix to Report First Quarter 2026 Financial Results
- Press releaseBusiness Wire
Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX
- Press releaseBusiness Wire
Orthofix Realigns Spine Leadership to Strengthen Focus and Execution
- Press releaseBusiness Wire
Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights
- Press releaseBusiness Wire
OFIX Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Orthofix Medical Inc. – OFIX
- Press releaseBusiness Wire
Orthofix Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Orthofix Medical, Inc. – OFIX
- News
A Glimpse Into The Expert Outlook On Orthofix Medical Through 5 Analysts
- News
Orthofix Medical Earnings Review: Q4 Summary
- News
Orthofix Medical Q4 Adj. EPS $0.24 Beats $0.12 Estimate, Sales $219.911M Beat $218.861M Estimate.
- Press releaseBusiness Wire
Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
- News
Earnings Outlook For Orthofix Medical
- Press releaseBusiness Wire
Orthofix to Participate in Upcoming Investor Conferences
- Press releaseGlobe Newswire
Fox Factory Announces Strategic Board Refresh
- Press releaseBusiness Wire
Orthofix to Report Fourth Quarter and Full-Year 2025 Financial Results
- Press releaseBusiness Wire
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
- Press releaseBusiness Wire
Orthofix Reports Third Quarter 2025 Financial Results
- News
Insights Ahead: Orthofix Medical's Quarterly Earnings
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.